John L. Marshall, MD, provides insight into the SUNLIGHT study findings presented during the 2023 ASCO Gastrointestinal Cancers Symposium.
ASCO Gastrointestinal Cancers Symposium 2023
The effect of ctDNA in the GI cancer treatment landscape are illustrated by Dr Marshall.
A medical expert discusses real-world analyses surrounding the use of ctDNA.
Dr Marshall shares insights directed at the use of real-world evidence [RWE] and its impact on unmet needs in colorectal cancer [CRC] treatment.
The SPOTLIGHT study results presented at the 2023 ASCO GI Cancers Symposium are explored by Dr Marshall.
In his closing thoughts, Dr Marshall shares final takeaways from the 2023 ASCO GI Cancers Symposium.
Advertisement
Advertisement
Trending on AJMC
1
Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD
2
Survodutide Normalizes Liver Fat in 61% of Patients With MASLD in Phase 3 Trial: Lee Kaplan, MD, PhD
3
Nutrition in Pregnancy May Shape Metabolic Health After Delivery
4
Bridging Science and Reality in Diabetes Care
5